Summary
- Sun Pharmaceutical Industries Limited has launched the Sun Professorship in Dermatology at the Icahn School of Medicine at Mount Sinai, backed by a $2.5 million endowment.
- Dr. Mark G. Lebwohl, a leader in psoriasis research, has been appointed as the inaugural professor during a ceremony at The Mount Sinai Hospital.
- This initiative aims to enhance research, education, and mentorship in dermatology, reflecting Sun Pharma's commitment to advancing patient care through scientific innovation.
- The professorship signifies a strategic partnership between Sun Pharma and Mount Sinai to support the next generation of dermatologists and improve patient outcomes globally.
Join the discussion ā sign up to comment, upvote, and save articles.